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Abstract
AIM: To propose an allocation system of patients 
with liver cirrhosis to intensive care unit (ICU), and 
developed a decision tool for clinical practice. 
METHODS: A systematic review of the literature 
was performed in PubMed, MEDLINE and EMBASE 
databases. The search includes studies on hospitalized 
patients with cirrhosis and organ failure, or acute on 
chronic liver failure and/or intensive care therapy. 
RESULTS: The initial search identified 660 potentially 
relevant articles. Ultimately, five articles were selected; 
two cohort studies and three reviews were found 
eligible. The literature on this topic is scarce and 
no studies specifically address allocation of patients 
with liver cirrhosis to ICU. Throughout the literature, 
there is consensus that selection criteria for ICU 
admission should be developed and validated for 
this group of patients and multidisciplinary approach 
is mandatory. Based on current available data we 
developed an algorithm, to determine if a patient is 
candidate to intensive care if needed, based on three 
scoring systems: premorbid Child-Pugh Score, Model 
of End stage Liver Disease score and the liver specific 
Sequential Organ Failure Assessment score.
CONCLUSION: There are no established systems for 
allocation of patients with liver cirrhosis to the ICU and 
no evidence-based recommendations can be made. 
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and high 28-d mortality rate[6]”. Since ACLF affects 
approximately 30% of hospitalised cirrhotic patients, 
ACLF is the most frequent indication for admission to 
the ICU[4,5]. However, the mortality among patients 
admitted to the ICU with ACLF is high[7]. Consequently, 
clinical awareness on identification of cirrhotic patients 
at risk of developing organ failure, who will benefit from 
early intensive care treatment, is of great importance. 
The mortality among patients admitted to the ICU with 
ACLF ranges between 35%-93%[2,5,7]. Patients requiring 
mechanical ventilation are high-risk patients with 
poor long-term survival with a 1-year mortality rate of 
89%[8]. Kavli et al[7] have shown that among patients 
with clinical or histological diagnosed alcoholic liver 
cirrhosis, in need for intensive care treatment, the 90-d 
mortality reaches levels of up to 93%, dependent on 
the degree of organ system failure[7]. Due to the poor 
prognosis the utilization of organ support in the ICU for 
these patients is often questioned. The treatment of 
patients with ACLF, not eligible for liver transplantation, 
is complicated and must be managed with therapies, 
which require a highly specialized team and close 
collaboration between hepatologists and intensive 
care specialists. There is a need for clinical tools and a 
proper triage to guide the physicians in decision making 
regarding the allocation of patients with ACLF to ICU, 
admitting only patients who would likely benefit from 
intensive care treatment[7]. In this study we aimed to 
perform a systematic review regarding allocation of 
patients with liver cirrhosis to intensive care, and to 
propose a decision tool for clinical practice. 
MATERIALS AND METHODS
An electronic search was performed in PubMed, 
MEDLINE and EMBASE. Studies were included in the 
search irrespective of blinding, publication status, or 
language, and manual searches including scanning 
of reference lists in relevant articles and conference 
proceedings was also performed. All studies responding 
to the issue of this article were eligible for analysis, 
including previous reviews. 
Criteria for considering studies for this review 
The present systematic search includes studies on 
hospitalized patients with cirrhosis and organ failure or 
acute on CLIF and/or intensive care therapy. 
Search methods for identification of studies 
String 1: “liver cirrhosis” or “hepatic cirrhosis”; String 
2: “liver failure” or “hepatic failure”; String 3: “intensive 
care” or “intensive treatment” or “intensive therapy” or 
“critical care”.
Potentially eligible studies were listed and eva-
luated. After reading the titles and abstracts, clearly 
irrelevant trials were excluded. Afterwards relevant full 
text studies were evaluated, and the eligible studies 
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Core tip: The literature regarding allocation of 
cirrhotic patients to intensive care unit (ICU) is very 
limited and no studies have proposed and tested 
any specific allocation criteria. Thus it still remains to 
be determined, which cirrhotic patients will benefit 
from intensive care treatment, and if so, when during 
admission they should be transferred to the ICU, 
and when intensive treatment is futile and should be 
withheld. We propose an allocation system for clinical 
practice, based on internationally validated scoring 
systems. 
Lindvig KP, Teisner AS, Kjeldsen J, Strøm T, Toft P, Furhmann 
V, Krag A. Allocation of patients with liver cirrhosis and organ 
failure to intensive care: Systematic review and a proposal for 
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Available from: URL: http://www.wjgnet.com/1007-9327/full/
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INTRODUCTION
The incidence of liver cirrhosis is increasing[1,2]. In the 
western world liver cirrhosis is mainly related to the 
increasing burden of alcohol-related liver disease, non-
alcoholic fatty liver disease and currently also hepatitis 
C, in the eastern world hepatitis B is a main cause. 
Patients with liver cirrhosis are prone to a progressive 
deterioration with the occurrence of portal hypertension 
and hepatic failure leading to end-stage liver disease 
and the development of complications. Furthermore, a 
large group (up to 75%) of patients are first diagnosed 
with liver cirrhosis, when experiencing their first episode 
of decompensation, and thus these patients represents 
a large hidden burden of the disease[3]. Patients with 
advanced liver cirrhosis, frequently require admission 
to intensive care unit (ICU)[4], mainly for various 
complications of advanced liver disease (i.e., sepsis, 
variceal bleeding, hepatic encephalopathy, spontaneous 
bacterial peritonitis, hepato-renal syndrome). These 
complications are associated with high risk of organ 
failures and a high mortality. Patients with cirrhosis 
presenting with acute hepatic deterioration and 
progressive organ failure represent the, now well 
described, syndrome acute-on-chronic-liver failure 
(ACLF)[5,6]. The Chronic Liver Failure (CLIF) ACLF in 
cirrhosis (CANONIC) study investigators of the European 
Association for the Study of the Liver - Chronic Liver 
Failure Consortium (EASL-CLIF) originally introduced 
the concept of ACLF: “ACLF is based on the presence 
of three major characteristics of the syndrome; acute 
decompensation, organ failure [predefined by the Clif 
Sequential Organ Failure Assessment (SOFA) score] 
were selected (Figure 1). 
RESULTS
The initial search identified 660 articles, 402 articles 
were indexed in PubMed, and 258 indexed in EMBASE. 
After duplicates were removed 584 articles, were 
evaluated for relevance.
During the initial title screening process 505 articles 
where evaluated by title of the first author, and found 
not relevant for the specific topic of this article, and 
therby excluded from the study. Further 67 articles 
were excluded after reading the abstracts, leaving 12 
potentially relevant articles to be evaluated in full text 
together with a review of references in these articles. 
Ultimately, five articles were selected; two cohort 
studies and three reviews were found in the systematic 
search to be eligible for the present review (Figure 1). 
Table 1 summarizes the main findings of the included 
studies. 
Cohort studies 
Kavli et al[7] performed a retrospective cohort study 
including 87 patients admitted to an ICU, at a university 
hospital with primary and secondary referrals. They 
found that increasing numbers of organ failures, 
correlate with increased mortality in critically ill patients 
with alcoholic liver cirrhosis. Interestingly they found 
that in patients with 3 or more organ failures the ICU 
mortality was > 90% (Table 1). Furthermore, they 
found the prognostic scores specific for critical illness 
to be superior at predicting outcome compared to the 
liver-specific Child-Pugh score. 
Shawcross et al[1] performed a prospective analysis 
of 563 patients admitted to a liver ICU with diagnosis of 
cirrhosis and dysfunction of one or more extrahepatic 
organ(s). They assessed resource utilization and found 
that presence of organ failure resulted in considerable 
resource expenditure in patients with liver cirrhosis, but 
had hospital mortality of 59% as illustrated in Table 1. 
Reviews
Ginès et al[9] performed a review with focus on the 
diagnostic approach and the currently recommended 
treatment strategy of critically ill cirrhotic patients. 
They report no new data, and no methods section 
is described. However, they describe that several 
studies have shown that relatively good results can 
be obtained in selected critically ill cirrhotic patients, 
and therefore reluctance to refer these patients to the 
ICU should be balanced. They suggest that patients 
with a low Model of End-stage Liver Disease (MELD 
score) (< 15) should be immediately considered for 
ICU. Contrary, in patients with end-stage cirrhosis 
(MELD > 30), 3 or more organ failures, and no per-
spective of transplantation, aggressive management is 
questionable. 
Berry et al[10] performed a review within the field of 
cirrhotic patients and allocation to ICU. They reported 
no new data, and the methods section was sparsely 
described. They suggest that an aggressive approach to 
organ support is justified, and that further discussions 
between hepatologists and intensive care specialists 
are required to determine acceptable burden-to-benefit 
ratios for prolonged intensive care support in young 
alcoholic patients. 
Saliba et al[11] performed a review within the field of 
cirrhotic patients and allocation to ICU. They reported 
no new data, and no methods section was described. 
However, they claimed that general ICU prognostic 
scores [SOFA score, Acute Physiology and Chronic 
Health Evaluation (APACHE) Ⅱ and SAPS Ⅱ] predicted 
mortality better than liver specific scores (MELD and 
Child-Pugh score) in cirrhotic patients, once admitted 
to the ICU. Furthermore, ICU and liver scores predicted 
outcome more precisely once they were re-evaluated 
at day 3 from admission. The authors stated that 
patients should be referred from the hepatology ward 
to the ICU at an earlier stage of decompensation, and 
a multidisciplinary approach between hepatologists, 
intensive care specialists, and also transplant surgeons 
should be mandatory. 
Scoring systems 
A number of score systems have been developed to 
assess the prognosis of critically ill cirrhotic patients, 
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Titles and abstracts identified 
through database searching
n  = 660
Records after duplicates 
removed
n  = 584
Records after title screening 
Abstracts
n  = 79
Full text articles assessed for 
eligibility
n  = 12
Studies included in final review
n = 5
Excluded based 
on abstract 
n  = 67
Excluded full-
text studies 
n  = 7
Excluded 
based on title 
n = 505
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Figure 1  Flowchart of trials. Flowchart of search string.
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see Table 2[2,12-35]. The liver specific scores have mainly 
focused on the general prognosis of cirrhotic patients, 
whereas the general scores, such as APACHE score, 
and SOFA score, were developed to predict outcome 
in the general population admitted to the ICU[5,14,20]. 
Numerous organ-failure scores have been developed 
to evaluate the prognosis depending on the number of 
organ failures, however, only a limited number of score 
systems have been established in clinical practice. To 
assess severity and prognosis due to underlying liver 
disease before ACLF or acute hospitalization, Child-
Pugh score and MELD score are the best-validated 
scores[14]. The World Health Organization (WHO) 
performance status (PS) is also useful to grade general 
well-being and activities of daily life.
The prognostic liver specific score named Child-
Pugh score (Table 3) contains five components; 
grade of hepatic encephalopathy, presence of ascites, 
serum-bilirubin, serum-albumin, and the international 
normalized ratio for prothrombin time (INR)[36]. 
Child Pugh score
The Child-Pugh score has been well established in 
clinical practice for decades. It contains a limited 
number of variables, is simply calculated, and is 
easily interpreted. The score is a simple method for 
determining the prognosis of patients with cirrhosis[15]. 
However, the Child-Pugh score does not take factors 
such as cardiovascular, renal, and pulmonary dys-
function into account, consequently it does not offer 
valid information to predict mortality in cirrhotic patients 
who have organ failure[14]. Further, the assessment of 
hepatic encephalopathy and presence of ascites are 
subjective measures and prone to observer variation.
MELD score
The MELD score is a scoring system for assessing 
the severity of chronic liver disease. The MELD Score 
ranges from 6 (less sick) to 40 (very sick) and the 
formula is based on the natural logarithm of serum 
bilirubin, serum creatinine, the INR for prothrombin 
time, and information regarding dialysis[37]. 
The MELD Score formula: [0.957 × ln[serum 
creatinin] + 0.378 × ln[serum bilirubin] + 1.120 × 
ln[INR] + 0.643] × 10 (if hemodialysis, value for 
Creatinine is automatically set to 4.0). 
Serum bilirubin is a blood sample that reflects the 
liver function. (Reference interval: 5-25 µmol/L). The 
INR reflects the ability of the liver to produce proteins; 
more specifically the clotting factors that contribute to 
the coagulation process (Reference interval: 0.8-1.2 
is normal, higher is abnormal). Creatinine is a blood 
sample that reflects the function of the kidneys. 
(Reference interval: 60-105 µmol/L). 
The MELD score is widely used to quantify end-stage 
liver disease in patients listed for liver transplantation[15], 
and has been repeatedly shown to be equivalent or 
even superior to the Child-Pugh score to estimate short-
term survival among cirrhotic patients[14]. An additional 
advantage of MELD is the exclusion of subjective 
measures.
WHO performance score
The performance score was originally introduced in the 
treatment of cancer patients, as an attempt to quantify 
cancer patients’ general well-being and activities of 
daily life (Table 4)[38]. The score is widely used in other 
medical conditions as a simple measure of general 
condition, functional ability and quality of life. 
APACHE scores 
The APACHE score is one of several ICU scoring 
systems. The score is a severity-of-disease classification 
system, based on 12 physiological parameters; 1, 
alveolar-arterial O2 tension difference (AaDO2) or 
arterial oxygen tension (PaO2) (depending on the 
fraction of inspired oxygen); 2, temperature (rectal); 3, 
mean arterial pressure; 4, arterial pH; 5, heart rate;, 
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Table 2  Scoring systems to predict mortality
Score Target Number of 
studies
AUCROC range 
(min-max)
Child-Pugh Prognostic1 14 0.71-0.87
MELD Prognostic1   8 0.77-0.93
RFH Prognostic1   1 0.79
SOFA Organ failure2 11 0.81-0.95
APACHE Ⅱ Prognostic in 
ICU3
  9 0.66-0.83
APACHE Ⅲ Prognostic in 
ICU3
  4 0.78-0.91
1Prognostic: score used to assess the prognosis of chronic liver disease; 
2Organ failure: score with the objective to evaluate the degree of organ 
failure; 3Prognostic in ICU: severity of disease classification score. The table 
describes the performance of the presented scoring systems[17,19-35]. AUROC: 
Areal Under the Reciever Operating Curve; Range (min-max) describing 
the minimum and maximum reported AUC for the given score, based on 
published trials[17,19-35]. ICU: Intensive care unit; MELD: Model of End-stage 
Liver Disease; RFH: Royal Free Hospital Score; SOFA: Sequential Organ 
Failure Assessment score; APACHE: Acute Physiology and Chronic Health 
Evaluation.
Table 3  Child-Pugh score
Measure 1 point 2 points 3 points
Total billirubin
(µmol/L)
< 34 
(< 1.9 mg/dL)
34-50 
(< 1.9-2.9 mg/dL)
> 50 
(> 2.9 mg/dL)
S-Albumin (g/L) > 35 28-35 < 28
PT INR < 1.70 1.71-2.30 > 2.30
Ascites None Mild Moderate/severe
Hepatic 
encephalopathy
None Grade Ⅰ-Ⅱ Grade Ⅲ-Ⅳ
Points Class One year survival Two year survival
5-6 A 100% 85%
7-9 B   81% 57%
10-15 C   45% 35%
Child-Pugh Score and associated one- and two-year survival.
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6, respiratory rate; 7, sodium (serum); 8, potassium 
(serum); 9, Creatinine; 10,. Haematocrit; 11, white 
blood cell count; and 12; Glasgow Coma Scale. The 
score is applied within 24 h of admission to the ICU, the 
higher the score, the higher risk of death[15]. Compared 
to Child-Pugh scores it has been shown in numerous 
studies to be more powerful in predicting hospital 
mortality in patients with liver cirrhosis. Wehler et al[39] 
found an areal under the receiver operating curve 
(AUROC) of 0.79 for the APACHE Ⅱ score, compared to 
Child-Pugh with an AUROC of 0.73, other studies have 
found similar results[24-26,28]. 
SOFA Score and CLIF-SOFA
The SOFA score was developed as a simple prognostic 
score to evaluate the degree of organ failure in 
patients in the general ICU[2,29]. The score contains 
information on degree of failure regarding liver, 
kidney, brain, coagulation, circulation and lungs, 
graded from 0-4 (Table 5). The CLIF-SOFA score is a 
modified version of the original SOFA score, a newly 
developed scoring system exclusively for patients 
with end-stage liver disease, and it accommodates a 
lower threshold for serum creatinine, because minor 
increases in s-creatinine levels in cirrhotic patients 
indicate marked reductions in glomerular filtration 
rate. Furthermore, it uses the INR instead of platelets 
as a marker of coagulaopathy, increases the threshold 
for bilirubin to achieve organ failure, and uses grades 
of hepatic encephalopathy from the West Haven score 
as opposed to Glasgow Coma Scale for neurologic 
failure[2,6]. Organ failure in the CLIF SOFA score is 
defined as; liver failure: bilirubin > 205 µmol/L, 
kidney failure: creatinine > 177 µmol/L or requiring 
renal replacement therapy, neurologic failure: hepatic 
encephalopathy grade 3 or 4, coagulation failure: INR 
> 2.5, and circulation failure: requiring vasopressors 
to maintain adequate mean arterial pressure (MAP). 
The CLIF-SOFA score can be translated into a degree 
of ACLF[6,40] (Figure 2, Tables 5 and 6). 
Royal Free Hospital score 
The Royal Free Hospital (RFH) score is a novel 
prognostic model for critically ill patients with cirrhosis. 
Parameters included in the score are bilirubin, INR, 
lactate, urea, A-a gradient, and variceal bleeding. 
Theocharidou et al[18], found the RFH score to have 
good discriminative power, equally to the CLIF-SOFA 
and SOFA score, however, the score remains to be 
externally validated, to confirm the clinical utility.
DISCUSSION
The decision-making regarding allocation of cirrhotic 
patients to ICU remains a great interdisciplinary 
challenge in daily clinical practice. The literature 
is scarce and no studies specifically address this 
issue. There is general consensus that selection 
criteria for ICU admission candidates should be 
developed and validated for this group of patients and 
multidisciplinary approach is mandatory. However, 
all together the general approach throughout the 
literature is somewhat indefinable. It still remains to 
be determined, which cirrhotic patients will benefit 
from intensive care treatment, and if so, when during 
admission they should be transferred to the ICU, and 
contrary when intensive treatment is futile and should 
be withheld.
It has been known for more than 40 years that 
surgical procedures on cirrhotic patients is associated 
with increased risk[35], and for cirrhotic patients 
(child-pugh C) who undergo nontransplant surgical 
procedures, mortality rates of up to 76% have been 
reported[41]. Furthermore it is known that the mortality 
rate is markedly increased for emergency surgery 
(57%) compared to elective surgery (10%)[42]. Higher 
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Table 4  World Health Organization performance score
Grade WHO Performance score
0 Fully active, able to carry on all pre-disease performance 
without restriction
1 Restricted in physically strenuous activity but ambulatory and 
able to carry out work of a light or sedentary nature, e.g., light 
house work, office work
2 Ambulatory and capable of all selfcare but unable to carry out 
any work activities. Up and about more than 50% of waking 
hours
3 Capable of only limited selfcare, confined to bed or chair more 
than 50% of waking hours
4 Completely disabled. Cannot carry on any selfcare, totally 
confined to bed or chair
5 Dead
Acute event
Stable cirrhosis
Progressive chronic liver failure Deterioration in organ function
Organ failure occurs
Point of no return
Pr
og
no
si
s
Time
Figure 2  Acute on Chronic Liver Failure. The green line illustrates a patient 
with stable cirrhosis (i.e., Child-Pugh class A/B) developing acute on chronic 
liver failure (ACLF). The red line illustrates a patient with progressive chronic 
liver failure (i.e., a patients with Child C cirrhosis and refractory ascites) 
developing ACLF. The Y-axis (Prognosis) is based on Child Pugh score or 
MELD score and the performance status before ACLF develops and CLIF-SOFA 
score after ACLF. The threshold “deterioration in organ function” represents a 
level with i.e. increase in creatinine or oxygen demand without organ failure. 
The threshold “organ failure” is as defined in the CLIF-SOFA score and “point of 
no return” is a state of multiorgan failure without reversibility.
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WHO: World Health Organization.
risk of infection, coagulopathy and malnutrition may 
be important factors[43-47]. In addition many cirrhotic 
patients decompensate in the postoperative phase and 
develop hepatic encephalopathy, ascites, hepato-renal 
syndrome or infections[44,45,47,48]. Reduced perfusion of 
the liver and altered response to anaesthetics and other 
medications, may also be contributing factors[49,50]. 
It is therefore essential to assess the severity of the 
underlying liver disease and to perform preoperative 
optimisation, including treatment of coagulopathy, 
ascites, portal hypertension, malnutrition, any substance 
abuse problem and infections. 
Based on current available data[5,6], we have de-
veloped an algorithm based on three scoring systems: 
Child-Pugh Score, MELD score and CLIF-SOFA score. In 
Figure 3 we suggest criteria to determine if a patient is 
a candidate to intensive care if needed. However, the 
algorithm remains to be validated in clinical practice.
The exact time point when patients should be 
referred to intensive care may be difficult to identify 
and will likely depend on local clinical setup, i.e., access 
to intermediate care. However, the following general 
consideration can be used. Dialogue between physicians 
from the referring ward and ICU is mandatory and 
should be initiated at an early stage to assess if the 
patient is candidate to intensive care if needed and to 
ensure detection and treatment of organ failures as 
early as possible. 
Close monitoring of progressive organ dysfunction in 
the ward is essential. Sometimes it may also be rational 
to transfer patients to the intermediate care/ICU to 
prevent occurrence of organ failure by close monitoring. 
Referral criteria should include the following: (1) 
Comatose patients not able to protect airways; (2) 
Respiratory failure with need of mechanical ventilation; 
(3) Circulatory failure with systolic blood pressure < 
90 mmHg or low mean arterial pressure (MAP < 60 
mmHg) despite adequate fluid supplementation and 
increasing lactate or increasing creatinine or reduced 
urine output; (4) necessity of vasopressors; and (5) 
septic shock or multi-organ failures.
To help the daily registration of important values 
in patients with liver cirrhosis, we have developed a 
specific computer software program First Chronic Liver 
Allocation Scoring System (First-CLASS). 
First-CLASS features an extensive data-gathering 
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Table 5  Chronic Liver Failure-Sequential Organ Failure Assessment score
Organ Variabel 0 1 2 3 4
Liver Billirubin, µmol/L < 20 µmol/L ≥ 20 to < 34 µmol/L ≥ 34 to < 103 µmol/L ≥ 103 to < 205 µmol/L > 205 µmol/L
(mg/dL) (-1.1) (≥ 1.1 to < 1.9 ) (≥ 1.9 to < 6.0) (≥ 6.0 to < 11.9) (> 11.9)1
Kidney Creatinine, µmol/L < 106 µmol/L ≥ 106 to < 177 µmol/L ≥ 177 to < 309 µmol/L ≥ 309 to < 442 µmol/L > 442 µmol/L
(mg/dL) (< 1.2) (≥ 1.2 to < 2.0) (≥ 1.2 to < 3.5)1 (≥ 3.5 to < 5)1 (> 5.0)1
Or renal replacement therapy1
CNS HE grade None Ⅰ Ⅱ Ⅲ1 Ⅳ1
Coagulation INR < 1.1 ≥ 1.1 to 1.25 ≥ 1.25 to < 1.5 ≥ 1.5 to < 2.5 ≥ 2.5 or platlets < 201
Circulation MAP (mmHg) ≥ 70 < 70 Dopamine ≤ 51 Dopamine > 51 Dopamine > 15
Dobutamine Epinephrine ≤ 0.11 Epinephrine > 0.1
Terlipressin1 Norepinephrine ≤ 0.11 Norepinephrine > 0.11
Lungs PaO2/FiO2 > 400 > 300 to ≤ 400 > 200 to ≤ 300 > 100 to ≤ 2001 ≤ 1001
SpO2/FiO2 > 512 > 357 to ≤ 512 > 214 to < 357 > 89 to ≤  2141 ≤ 891
1Indicates the limit for the definition of organ failure. HE: Hepatic encephalopathy; MAP: Mean arterial pressure; PaO2: Arterial oxygen tension; FiO2: 
Fraction of inspired oxygen; SpO2: Peripheral capillary oxygen saturation. 
Table 6  Degree of Acute on Chronic Liver Failure and the 
associated mortality
ACLF Numbers of organ failure 28-d mortality 90-d mortality
0 0 or 1 (/kidney)   4.7% 15.0%
1 1 (no kidney dysfunction) 22.1% 40.7%
2 2 32.0% 52.3%
3 ≥ 3 76.7% 79.1%
ACLF: Acute on Chronic Liver Failure.
Intensive care candidate 
Premorbid Child-Pugh A/B (5-9 
points) or MELD score < 15 and 
ACLF grade ≤ 2 with the need for 
intensive therapy, e.g.,  HE > 2 or 
respiratory insufficiency 
Possible intensive care candidate, 
eligibility should be considered and 
discussed with ICU
Premorbid Child-Pugh A/B (5-9 
points) or MELD score < 15 and ACLF 
grade ≥ 3 or
Premorbid Child-Pugh C (10-15 
points) or MELD score 16-29 and 
ACLF ≤ 2
If continuous organ failure is present 
after 3 d of complete intensive 
care treatment, the outcome is 
questionable
Unlikely to benefit from intensive 
care therapy Premorbid Child-Pugh C (10-15 
points) or MELD score > 30 and ACLF 
grade ≥ 3
Special cases can be disussed, e.g. , 
patients that are candidate for liver 
transplantation
Figure 3  Proposal of a clinical system to identify candidates for intensive 
care if indicated. Algorithm based on three scoring systems: Child-Pugh 
Score, Model of End stage Liver Disease score (MELD) and Sequential Organ 
Failure Assessment score (CLIF-SOFA). ACLF: Acute on chronic liver failure; 
ICU: Intensive care unit.
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tool, with a user-friendly graphical interface, for 
the purpose of scoring acute on CLIF patients. An 
immediate score of the patient is calculated using 
the described algorithm, and it will be presented to 
the user. All data is saved to a database, which can 
be easily retrieved for both research and evaluation 
of specific patients. First-CLASS provides a program 
for viewing the data that has been collected in a 
meaningful way, such as using graphs for visualization 
of results in the given admission period. Furthermore 
the First-CLASS-Viewer program allows for exporting 
the data of patients to be used directly for statistical 
analysis (Figure 4). 
In conclusion, we found that the literature regarding 
allocation of cirrhotic patients to ICU is very limited 
and no studies have proposed and tested any specific 
allocation criteria. Thus it still remains to be determined, 
which cirrhotic patients will benefit from intensive care 
treatment, and if so, when during admission they 
should be transferred to the ICU, and when intensive 
treatment is futile and should be withheld. Based on 
indirect evidence we have proposed a scoring system 
that can help identify which patients are candidates 
or not to ICU therapy, however the system needs 
validation.
COMMENTS
Background
Patients with liver cirrhosis are prone to a progressive disease course with 
the occurrence of portal hypertension and hepatic failure leading to end-stage 
disease and development of complications. Cirrhosis and organ failure is 
associated with a high mortality. Rational and timely allocation to an intensive 
care unit (ICU) is a challenge of clinical importance. 
Research frontiers
The exact time point when patients should be referred to intensive care may 
be difficult to identify and will likely depend on local clinical setup, i.e., access 
to intermediate care. Close monitoring of progressive organ dysfunction in 
the ward is essential. Sometimes it may also be rational to transfer patients 
to the intermediate care/ICU to prevent occurrence of organ failure by close 
monitoring. Referral criteria should include the following: (1) Comatose patients 
not able to protect airways; (2) Respiratory failure with need of mechanical 
ventilation; (3) Circulatory failure with systolic blood pressure < 90 mmHg 
or low mean arterial pressure (MAP < 60 mmHg) despite adequate fluid 
supplementation and increasing lactate or increasing creatinine or reduced 
urine output; (4) necessity of vasopressors; and (5) septic shock or multi-organ 
failures.
Innovations and breakthroughs
To help the daily monitoring and registration of organfunctions in patients with 
liver cirrhosis, the authors have developed computer software program First 
Chronic Liver Allocation Scoring System (First-CLASS). First-CLASS features 
an extensive data-gathering tool, with a user-friendly graphical interface, for the 
purpose of scoring acute on chronic liver failure (CLIF) patients. An immediate 
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Figure 4  First Chronic Liver Allocation Scoring system. Danish civil registration number, a unique 10-digit personal identification number assigned to every 
Danish citizen at birth since 1968. HE: Hepatic encephalopathy; CP Score: Child Pugh Score; MAP: Mean arterial pressure; SAT: Oxygen saturation (%); Varice 
Haemorr: Variceal haemorrhage; S.B. Peritonitis: Spontaneous bacterial peritonitis; Alko. Hepatitis: Alcoholic hepatitis; HRS: Hepato renal syndrome; WHO Perform: 
WHO performance status; ACLF grade: Acute on chronic liver failure grade; First-CLASS: First Chronic Liver Allocation Scoring System; SSN: Social Security Number.
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score of the patient is calculated using the described algorithm, and it will be 
presented to the user. 
Applications
It still remains to be determined, which cirrhotic patients will benefit from 
intensive care treatment, and if so, when during admission they should be 
transferred to the ICU, and when intensive treatment is futile and should be 
withheld. Based on indirect evidence, the authors have proposed a scoring 
system that can help identify which patients are candidates or not to ICU 
therapy, however the system needs validation.
Terminology
Patients with cirrhosis presenting with acute hepatic deterioration and 
progressive organ failure represent the, now well described, syndrome 
Acute-on-Chronic-Liver Failure (ACLF). The CLIF ACLF in cirrhosis study 
investigators of the European Association for the Study of the Liver - Chronic 
Liver Failure Consortium originally introduced the concept of ACLF: “ACLF is 
based on the presence of three major characteristics of the syndrome; acute 
decompensation, organ failure (predefined by the CLIF SOFA score) and high 
28-d mortality rate”. 
Peer-review
In this manuscript “Allocation of patients with liver cirrhosis and organ failure 
to intensive care: Systematic review and a proposal for clinical practice”, the 
authors aimed to perform a systematic review regarding allocation of patients 
with liver cirrhosis to ICU. They also proposed a scoring system to help identify 
the patients as candidates for ICU therapy. The subject matter of current 
study is of interest. This review may help clinicians chose the more suitable 
treatments. 
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